Company / EPS (Diluted)
Niagen Bioscience, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.11
FY2025
5-year range
-$0.40 / $0.11
FY2021-FY2025
Trend
+257.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed +257% YoY in FY2025, a notable deviation from the 9-year average annual change of -21%.
Based on SEC 10-K filings.
0.11 in FY2025.
Improved from $-0.24 to $0.11 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s eps (diluted) has grown for 3 consecutive years.
- In FY2025, eps (diluted) increased 257.1% year-over-year.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | +257.1% |
| FY2024 | -$0.07 | +70.8% |
| FY2023 | -$0.24 | +40.0% |
| FY2022 | -$0.40 | -21.2% |
| FY2021 | -$0.33 | +41.1% |
| FY2020 | -$0.56 | +8.2% |
| FY2019 | -$0.61 | -134.6% |
| FY2018 | -$0.26 | -750.0% |
| FY2017 | $0.04 | +300.0% |
| FY2016 | $0.01 | +125.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026